The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung disease.

PubWeight™: 1.66‹?› | Rank: Top 3%

🔗 View Article (PMC 306592)

Published in EMBO J on August 01, 2000

Authors

M C Bordeaux1, C Forcet, L Granger, V Corset, C Bidaud, M Billaud, D E Bredesen, P Edery, P Mehlen

Author Affiliations

1: Laboratoire Apoptose et Différenciation, label La Ligue contre le Cancer et Laboratoire de Génétique Humaine - Centre de Génétique Moléculaire et Cellulaire, CNRS UMR 5534, Université Lyon 1, 69622 Villeurbanne, France.

Articles citing this

Netrin-1 acts as a survival factor via its receptors UNC5H and DCC. EMBO J (2001) 2.17

The dependence receptor DCC (deleted in colorectal cancer) defines an alternative mechanism for caspase activation. Proc Natl Acad Sci U S A (2001) 1.92

Inactivation of the UNC5C Netrin-1 receptor is associated with tumor progression in colorectal malignancies. Gastroenterology (2007) 1.83

A targeting mutation of tyrosine 1062 in Ret causes a marked decrease of enteric neurons and renal hypoplasia. Mol Cell Biol (2004) 1.44

Diminished Ret expression compromises neuronal survival in the colon and causes intestinal aganglionosis in mice. J Clin Invest (2008) 1.43

Netrin-1 acts as a survival factor for aggressive neuroblastoma. J Exp Med (2009) 1.36

Trafficking of receptor tyrosine kinases to the nucleus. Exp Cell Res (2008) 1.33

The TrkC receptor induces apoptosis when the dependence receptor notion meets the neurotrophin paradigm. Proc Natl Acad Sci U S A (2007) 1.26

Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage. Mol Cell Biol (2006) 1.19

Netrin-1 is a survival factor during commissural neuron navigation. Proc Natl Acad Sci U S A (2008) 1.16

Neurodegeneration in Alzheimer's disease: caspases and synaptic element interdependence. Mol Neurodegener (2009) 1.12

A founding locus within the RET proto-oncogene may account for a large proportion of apparently sporadic Hirschsprung disease and a subset of cases of sporadic medullary thyroid carcinoma. Am J Hum Genet (2002) 1.09

Proapoptotic function of the MET tyrosine kinase receptor through caspase cleavage. Mol Cell Biol (2004) 1.09

Genetic background impacts developmental potential of enteric neural crest-derived progenitors in the Sox10Dom model of Hirschsprung disease. Hum Mol Genet (2010) 1.06

Hypoxia induces netrin-1 and Unc5b in atherosclerotic plaques: mechanism for macrophage retention and survival. Arterioscler Thromb Vasc Biol (2013) 1.05

GDNF-deprived sympathetic neurons die via a novel nonmitochondrial pathway. J Cell Biol (2003) 1.03

Role for the pleckstrin homology domain-containing protein CKIP-1 in AP-1 regulation and apoptosis. EMBO J (2005) 1.02

Interfering with multimerization of netrin-1 receptors triggers tumor cell death. Cell Death Differ (2009) 1.01

Role of netrin-1 and netrin-1 dependence receptors in colorectal cancers. Br J Cancer (2005) 1.00

Protease regulation: the Yin and Yang of neural development and disease. Neuron (2011) 1.00

Dual neurotoxic and neuroprotective role of metabotropic glutamate receptor 1 in conditions of trophic deprivation - possible role as a dependence receptor. Neuropharmacology (2008) 0.99

RET is a potential tumor suppressor gene in colorectal cancer. Oncogene (2012) 0.98

The dependence receptor DCC requires lipid raft localization for cell death signaling. Proc Natl Acad Sci U S A (2006) 0.98

Whole-exome sequencing of muscle-invasive bladder cancer identifies recurrent mutations of UNC5C and prognostic importance of DNA repair gene mutations on survival. Clin Cancer Res (2014) 0.95

Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC-induced apoptosis. J Clin Invest (2010) 0.94

Receptor tyrosine kinases in the nucleus. Cold Spring Harb Perspect Biol (2013) 0.93

Dependence receptor TrkC is a putative colon cancer tumor suppressor. Proc Natl Acad Sci U S A (2013) 0.93

The dependence receptor Ret induces apoptosis in somatotrophs through a Pit-1/p53 pathway, preventing tumor growth. EMBO J (2007) 0.91

Structure and physiology of the RET receptor tyrosine kinase. Cold Spring Harb Perspect Biol (2013) 0.90

Dependence receptor UNC5D mediates nerve growth factor depletion-induced neuroblastoma regression. J Clin Invest (2013) 0.87

Regional differences in neural crest morphogenesis. Cell Adh Migr (2011) 0.86

DNA damage induces GDNF secretion in the tumor microenvironment with paracrine effects promoting prostate cancer treatment resistance. Oncotarget (2015) 0.83

A multi-factor model for caspase degradome prediction. BMC Genomics (2009) 0.83

Central role of RET in thyroid cancer. Cold Spring Harb Perspect Biol (2013) 0.79

RET modulates cell adhesion via its cleavage by caspase in sympathetic neurons. J Biol Chem (2011) 0.79

Molecular control of the neural crest and peripheral nervous system development. Curr Top Dev Biol (2015) 0.78

Correlation between multiple RET mutations and severity of Hirschsprung's disease. Pediatr Surg Int (2013) 0.78

Dependence receptors: mechanisms of an announced death. Cell Cycle (2010) 0.76

Increased cellular distribution of vimentin and ret in the cingulum of rat offspring after developmental exposure to decabromodiphenyl ether or 1,2,5,6,9,10-hexabromocyclododecane. J Toxicol Pathol (2013) 0.75

A PCR-mutagenesis strategy for rapid detection of mutations in codon 634 of the ret proto-oncogene related to MEN 2A. BMC Med Genet (2002) 0.75

Context is everything for dependence receptors in colorectal cancer. Proc Natl Acad Sci U S A (2013) 0.75

Microarray Analysis Reveals Increased Transcriptional Repression and Reduced Metabolic Activity but Not Major Changes in the Core Apoptotic Machinery during Maturation of Sympathetic Neurons. Front Cell Neurosci (2016) 0.75

RET haplotype, not linked to the C620R activating mutation, associated with Hirschsprung disease in a novel MEN2 family. Clinics (Sao Paulo) (2012) 0.75

Articles cited by this

Cadherin cell adhesion receptors as a morphogenetic regulator. Science (1991) 13.78

Regulation of cell death protease caspase-9 by phosphorylation. Science (1998) 11.26

A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem (1997) 9.97

Signaling through scaffold, anchoring, and adaptor proteins. Science (1997) 9.48

X-linked IAP is a direct inhibitor of cell-death proteases. Nature (1997) 8.26

Caspases: intracellular signaling by proteolysis. Cell (1997) 7.46

Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature (1995) 6.16

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature (1993) 5.81

Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature (1994) 5.61

An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. J Virol (1993) 5.15

Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature (1996) 4.37

Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell (1985) 3.86

GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science (1994) 3.63

Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature (1994) 3.46

Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature (1994) 3.33

Biochemical characteristics of caspases-3, -6, -7, and -8. J Biol Chem (1997) 3.04

Induction of apoptosis by the low-affinity NGF receptor. Science (1993) 3.04

GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell (1996) 2.86

Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science (1995) 2.83

The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature (1998) 2.81

Autoproteolytic activation of pro-caspases by oligomerization. Mol Cell (1998) 2.48

ret transforming gene encodes a fusion protein homologous to tyrosine kinases. Mol Cell Biol (1987) 2.48

GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron (1998) 2.34

Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol Cell Biol (1999) 2.17

Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival. J Neurosci (1998) 2.06

Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis. Oncogene (1998) 2.03

Neurturin, a relative of glial-cell-line-derived neurotrophic factor. Nature (1996) 1.83

Kennedy's disease: caspase cleavage of the androgen receptor is a crucial event in cytotoxicity. J Neurochem (1999) 1.66

Neurturin and GDNF promote proliferation and survival of enteric neuron and glial progenitors in vitro. Dev Biol (1998) 1.55

Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase/AKT signaling pathway. J Biol Chem (2000) 1.47

Signalling by the RET receptor tyrosine kinase and its role in the development of the mammalian enteric nervous system. Development (1999) 1.46

p75NTR and the concept of cellular dependence: seeing how the other half die. Cell Death Differ (1998) 1.40

Loss of function effect of RET mutations causing Hirschsprung disease. Nat Genet (1995) 1.33

TrnR2, a novel receptor that mediates neurturin and GDNF signaling through Ret. Neuron (1997) 1.20

Crystal structure of baculovirus P35: role of a novel reactive site loop in apoptotic caspase inhibition. EMBO J (1999) 1.16

Various mechanisms cause RET-mediated signaling defects in Hirschsprung's disease. J Clin Invest (1998) 1.10

An epidermal growth factor receptor/ret chimera generates mitogenic and transforming signals: evidence for a ret-specific signaling pathway. Mol Cell Biol (1994) 1.07

RET alternate splicing influences the interaction of activated RET with the SH2 and PTB domains of Shc, and the SH2 domain of Grb2. Oncogene (1997) 1.05

Identification of Shc docking site on Ret tyrosine kinase. Oncogene (1997) 1.04

Small stress protein Hsp27 accumulation during dopamine-mediated differentiation of rat olfactory neurons counteracts apoptosis. Cell Death Differ (1999) 0.97

Distinct biological properties of two RET isoforms activated by MEN 2A and MEN 2B mutations. Oncogene (1997) 0.97

Articles by these authors

Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ (2011) 9.44

Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg (1985) 5.91

Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science (1993) 4.53

Coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ (2004) 4.41

Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. Proc Natl Acad Sci U S A (1987) 3.98

Anti-cancer activity of targeted pro-apoptotic peptides. Nat Med (1999) 3.72

Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science (1996) 3.53

Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ (2009) 3.44

A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor. Nat Med (2000) 3.24

An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci U S A (2000) 3.13

Induction of apoptosis by the low-affinity NGF receptor. Science (1993) 3.04

Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene. J Virol (1991) 3.03

Coupling endoplasmic reticulum stress to the cell death program. Mechanism of caspase activation. J Biol Chem (2001) 2.86

The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature (1998) 2.81

Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23. J Virol (1990) 2.58

Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. Proc Natl Acad Sci U S A (1996) 2.50

Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates. Nat Genet (1998) 2.42

bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci U S A (1993) 2.39

Sensory neuropathy with low-dose pyridoxine. Neurology (1985) 2.30

Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J Biol Chem (1998) 2.23

Netrin-1 acts as a survival factor via its receptors UNC5H and DCC. EMBO J (2001) 2.17

Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome). Nat Genet (1996) 2.01

Establishment of a cell-free system of neuronal apoptosis: comparison of premitochondrial, mitochondrial, and postmitochondrial phases. J Neurosci (1997) 2.01

Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency. Lancet (2000) 2.00

TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus E1A protein. Proc Natl Acad Sci U S A (1993) 2.00

Human Bcl-2 reverses survival defects in yeast lacking superoxide dismutase and delays death of wild-type yeast. J Cell Biol (1997) 1.97

Cleavage of actin by interleukin 1 beta-converting enzyme to reverse DNase I inhibition. Proc Natl Acad Sci U S A (1996) 1.95

Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc Natl Acad Sci U S A (1999) 1.93

Telomere lengthening and telomerase activation during human B cell differentiation. Proc Natl Acad Sci U S A (1997) 1.93

The dependence receptor DCC (deleted in colorectal cancer) defines an alternative mechanism for caspase activation. Proc Natl Acad Sci U S A (2001) 1.92

Expression of the baculovirus p35 gene inhibits mammalian neural cell death. J Neurochem (1993) 1.85

Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells. J Biol Chem (2000) 1.79

Cerebral infarctions and transient neurologic deficits associated with acquired immunodeficiency syndrome. Am J Med (1989) 1.70

Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease. Hum Mol Genet (1995) 1.68

Mutation update for the CSB/ERCC6 and CSA/ERCC8 genes involved in Cockayne syndrome. Hum Mutat (2010) 1.67

The RET receptor: function in development and dysfunction in congenital malformation. Trends Genet (2001) 1.67

Kennedy's disease: caspase cleavage of the androgen receptor is a crucial event in cytotoxicity. J Neurochem (1999) 1.66

Netrin-1-mediated axon outgrowth and cAMP production requires interaction with adenosine A2b receptor. Nature (2000) 1.60

Analysis of mRNA decay and rRNA processing in Escherichia coli multiple mutants carrying a deletion in RNase III. J Bacteriol (1993) 1.59

Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc Natl Acad Sci U S A (1995) 1.51

Paraptosis: mediation by MAP kinases and inhibition by AIP-1/Alix. Cell Death Differ (2004) 1.50

Germline mutations of the RET ligand GDNF are not sufficient to cause Hirschsprung disease. Nat Genet (1996) 1.49

Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase/AKT signaling pathway. J Biol Chem (2000) 1.47

Mutation of the endothelin-receptor B gene in Waardenburg-Hirschsprung disease. Hum Mol Genet (1995) 1.45

Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease. Cell Death Differ (2004) 1.44

Interaction of BTG1 and p53-regulated BTG2 gene products with mCaf1, the murine homolog of a component of the yeast CCR4 transcriptional regulatory complex. J Biol Chem (1998) 1.41

T-cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny. Blood (1993) 1.40

The dependence receptor hypothesis. Apoptosis (2004) 1.40

Molecular analysis of pericentrin gene (PCNT) in a series of 24 Seckel/microcephalic osteodysplastic primordial dwarfism type II (MOPD II) families. J Med Genet (2009) 1.38

Receptors that mediate cellular dependence. Cell Death Differ (2005) 1.37

Abeta induces cell death by direct interaction with its cognate extracellular domain on APP (APP 597-624). FASEB J (2006) 1.35

TRAF family proteins interact with the common neurotrophin receptor and modulate apoptosis induction. J Biol Chem (1999) 1.35

The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor. J Biol Chem (1995) 1.35

Dependence receptors: a new paradigm in cell signaling and cancer therapy. Oncogene (2010) 1.31

Regulation of dauer larva development in Caenorhabditis elegans by daf-18, a homologue of the tumour suppressor PTEN. Curr Biol (1999) 1.31

Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade. Mol Cell Biol (2001) 1.29

Shift of the cellular oxidation-reduction potential in neural cells expressing Bcl-2. J Neurochem (1996) 1.29

The protooncogene bcl-2 inhibits apoptosis in PC12 cells. J Neurochem (1993) 1.28

Inhibition of I kappa B-alpha phosphorylation and degradation and subsequent NF-kappa B activation by glutathione peroxidase overexpression. J Cell Biol (1996) 1.26

Spectrum of NSD1 mutations in Sotos and Weaver syndromes. J Med Genet (2003) 1.26

Heat shock protein 27 enhances the tumorigenicity of immunogenic rat colon carcinoma cell clones. Cancer Res (1998) 1.25

Neuronal apoptosis induced by pharmacological concentrations of 3-hydroxykynurenine: characterization and protection by dantrolene and Bcl-2 overexpression. J Neurochem (2000) 1.22

HSP27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs. Cancer Res (1997) 1.22

Mutation of the RET ligand, neurturin, supports multigenic inheritance in Hirschsprung disease. Hum Mol Genet (1998) 1.19

Heterozygous endothelin receptor B (EDNRB) mutations in isolated Hirschsprung disease. Hum Mol Genet (1996) 1.19

Is apoptosis mediated by reactive oxygen species? Free Radic Res (1994) 1.18

Abnormal neuronal networks and seizure susceptibility in mice overexpressing the APP intracellular domain. Neurobiol Aging (2009) 1.16

Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature. Arthritis Res (2001) 1.16

Mutations in copper-zinc superoxide dismutase that cause amyotrophic lateral sclerosis alter the zinc binding site and the redox behavior of the protein. Proc Natl Acad Sci U S A (1996) 1.14

Neurosurgical implications of the acquired immunodeficiency syndrome (AIDS). Clin Neurosurg (1988) 1.13

Absence of p75NTR causes increased basal forebrain cholinergic neuron size, choline acetyltransferase activity, and target innervation. J Neurosci (1997) 1.12

Focal degeneration of astrocytes in amyotrophic lateral sclerosis. Cell Death Differ (2008) 1.11

The acquired immunodeficiency syndrome (AIDS) dementia complex. Ann Intern Med (1989) 1.10

Various mechanisms cause RET-mediated signaling defects in Hirschsprung's disease. J Clin Invest (1998) 1.10

GDNF triggers a novel ret-independent Src kinase family-coupled signaling via a GPI-linked GDNF receptor alpha1. FEBS Lett (1999) 1.09

Prion protein gene expression in cultured cells. Protein Eng (1988) 1.09

Netrin-1 interacts with amyloid precursor protein and regulates amyloid-beta production. Cell Death Differ (2009) 1.09

Activation of CPP32 during apoptosis of neurons and astrocytes. J Neurosci Res (1997) 1.09

A locus for autosomal dominant colobomatous microphthalmia maps to chromosome 15q12-q15. Am J Hum Genet (2000) 1.08

Expression of bcl-2 inhibits necrotic neural cell death. J Neurosci Res (1995) 1.08

Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival. Cancer Res (2000) 1.06

Bcl-2 protects against apoptosis in neuronal cell line caused by thapsigargin-induced depletion of intracellular calcium stores. J Neurochem (1998) 1.06

Expression of the low-affinity nerve growth factor receptor enhances beta-amyloid peptide toxicity. Proc Natl Acad Sci U S A (1994) 1.06

APAP, a sequence-pattern recognition approach identifies substance P as a potential apoptotic peptide. FEBS Lett (2001) 1.06

Central nervous system dysfunction in acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr (1988) 1.05

Endoplasmic reticulum stress-induced cell death mediated by the proteasome. Cell Death Differ (2007) 1.03

Double-stranded RNA-dependent protein kinase, PKR, binds preferentially to Huntington's disease (HD) transcripts and is activated in HD tissue. Hum Mol Genet (2001) 1.03

IL-4 induces LFA-1 and LFA-3 expression on Burkitt's lymphoma cell lines. Requirement of additional activation by phorbol myristate acetate for induction of homotypic cell adhesions. J Immunol (1989) 1.03

Role of c-myc in simian virus 40 large tumor antigen-induced DNA synthesis in quiescent 3T3-L1 mouse fibroblasts. Proc Natl Acad Sci U S A (1994) 1.03

Effect of overexpression of BCL-2 on cellular oxidative damage, nitric oxide production, antioxidant defenses, and the proteasome. Free Radic Biol Med (2001) 1.02